American Heart Journal
Volume 153, Issue 1 , Pages 82.e1-82.e11, January 2007

Carvedilol use at discharge in patients hospitalized for heart failure is associated with improved survival: An analysis from Organized Program to Initiate Lifesaving Treatment in Hospitalized Patients with Heart Failure (OPTIMIZE-HF)

  • Gregg C. Fonarow, MD

      Affiliations

    • Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, Los Angeles, CA
    • Corresponding Author InformationReprint requests: Gregg C Fonarow, MD, Ahmanson-UCLA Cardiomyopathy Center, UCLA Medical Center, 10833 LeConte Avenue, Room 47-123 CHS, Los Angeles, CA 90095-1679.
    • ,
  • William T. Abraham, MD

      Affiliations

    • Division of Cardiology, Ohio State University, Columbus, OH
    • ,
  • Nancy M. Albert, RN, PhD

      Affiliations

    • Division of Nursing and George M and Linda H Kaufman Center for Heart Failure, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • Wendy Gattis Stough, PharmD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, NC
    • Department of Clinical Research, Campbell University School of Pharmacy, Research Triangle Park, NC
    • ,
  • Mihai Gheorghiade, MD

      Affiliations

    • Division of Cardiology, Feinberg School of Medicine, Northwestern University, Chicago, IL
    • ,
  • Barry H. Greenberg, MD

      Affiliations

    • Department of Medicine, USCD Medical Center-Hillcrest, University of California, San Diego, CA
    • ,
  • Christopher M. O'Connor, MD

      Affiliations

    • Division of Cardiology, Duke University Medical Center/Duke Clinical Research Institute, Durham, NC
    • ,
  • Jie Lena Sun, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, NC
    • ,
  • Clyde Yancy, MD

      Affiliations

    • Baylor Heart and Vascular Institute, Baylor University Medical Center, Dallas, TX
    • ,
  • James B. Young, MD

      Affiliations

    • Department of Cardiovascular Medicine, Heart Failure Section, Cleveland Clinic Foundation, Cleveland, OH
    • ,
  • on behalf of the OPTIMIZE-HF Investigators and Coordinators

Received 1 August 2006; accepted 11 October 2006.

Guest Editor of this manuscript is Hector O. Ventura, MD.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The OPTIMIZE-HF registry is registered: http://www.clinicaltrials.gov, study number NCT00344513 and was funded by GlaxoSmithKline.

PII: S0002-8703(06)00892-1

doi:10.1016/j.ahj.2006.10.008

American Heart Journal
Volume 153, Issue 1 , Pages 82.e1-82.e11, January 2007

Article Tools

* Image Usage & Resolution